Ambit, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Ambit, Inc. - overview
Established
2021
Location
Morristown, NJ, US
Primary Industry
Healthcare IT
About
Based in New Jersey, US, and founded in 2001, Ambit, Inc. operates as an analytics and technology-enabled solutions company. In September 2024, Ambit, Inc. raised USD 1 million in venture funding from HEST Investments.
As of 2024, the company is led by its CEO, Rob Sederman. Ambit’s product line includes Dynamic LeadGen, which is an AI/ML-powered solution designed to optimize HCP targeting and activation in the rare and specialty disease markets; and Patient Activate, which is a comprehensive patient-finding solution designed for biopharma companies that simplifies the process of identifying specialty and rare disease patients. Their services include commercial and medical strategy, data and analytics, patient identification and activation, digital transformation, and patient services.
Current Investors
HEST investments
Primary Industry
Healthcare IT
Sub Industries
Biopharmaceuticals, Healthcare IT, Analytics & Performance Software
Website
www.ambitinc.com/
Verticals
Artificial Intelligence, HealthTech
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.